DARPA
Antibodies eye Pacific Island “fever”
May. 14, 2020—Vanderbilt Vaccine Center team isolates monoclonal antibodies against the mosquito-borne Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months.
New method tested to block chikungunya infection
Jun. 14, 2019—Scientists are testing a new way to fight chikungunya virus that involves injecting genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies.
New way to stimulate learning?
Mar. 14, 2019—Stimulating the vagus nerve triggers certain epigenetic changes involving learning and memory.
Vanderbilt team wins $750K with AI to manage RF spectrum
Feb. 7, 2019—Scientists at Vanderbilt's Institute for Software Integrated Systems have developed an award-winning AI to to help triage limited radio frequency demands in real time.
VUMC scientists ‘sprint’ to find anti-Zika antibodies
Jan. 25, 2019—Scientists at Vanderbilt University Medical Center and colleagues in Boston, Seattle and St. Louis are racing to develop — in a mere 90 days — a protective antibody-based treatment that can stop the spread of the Zika virus.
New imaging approach offers unprecedented views of staph infection
Mar. 15, 2018—A new integrated imaging approach makes it possible to probe the molecules involved in invasive infections and can be broadly applied to any health or disease state.
Vanderbilt wins top prize in first round of DARPA Spectrum Collaboration Challenge
Jan. 30, 2018—The DARPA challenge seeks to uncover efficient solutions to our increasingly connected world's equally growing appetite for bandwidth.
VUMC joins national effort to block global pandemics of potentially lethal viruses
Jan. 11, 2018—The U.S. Defense Advanced Research Projects Agency (DARPA) has signed a five-year cooperative agreement worth up to $28 million with Vanderbilt University Medical Center (VUMC) to develop methods for preventing the global spread of viruses like chikungunya and Zika.
VU joins national effort to speed Ebola therapy testing
Apr. 8, 2015—Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.
Vanderbilt’s neurovascular chip project moves into new phase
Nov. 18, 2014—Vanderbilt researchers will play a key role in the second phase of the federal "tissue chip for drug screening" program.
Metro students make bicycle models with high-tech tools
Jun. 18, 2014—Thirteen Nashville public high school students are spending their summer mornings on the Vanderbilt campus building bicycle models using software tools developed to revolutionize the manufacturing of military vehicles.
Significant progress toward creating “benchtop human” reported
Mar. 27, 2014—Vanderbilt physicist John Wikswo reported significant progress toward creating “homo minutus” – a human-on-a-chip that can be used to test drugs and toxins – on Mar. 26 at the Society of Toxicology meeting in Phoenix.